Table 2.
Study participant demographic characteristics
| Placebo group (n = 21) | FRG group (n = 21) | p- value 1) | |
|---|---|---|---|
| Sex (M/F) |
15/6 |
13/8 |
0.5132) |
| Age (years) |
53.5 ± 1.9 |
53.2 ± 1.8 |
0.914 |
| Height (cm) |
165.0 ± 1.8 |
166.6 ± 1.4 |
0.477 |
| Weight (kg) |
67.5 ± 2.4 |
68.9 ± 1.8 |
0.646 |
| Waist (cm) |
91.1 ± 1.7 |
93.0 ± 1.3 |
0.406 |
| BMI (kg/m2) |
24.9 ± 0.8 |
24.9 ± 0.7 |
1.000 |
| Fasting plasma glucose (mmol/l) |
6.4 ± 0.6 |
6.5 ± 0.5 |
0.737 |
| Total cholesterol (mmol/l) |
4.8 ± 0.1 |
5.2 ± 0.2 |
0.121 |
| LDL cholesterol (mmol/l) |
2.9 ± 0.1 |
3.1 ± 0.1 |
0.414 |
| HDL cholesterol (mmol/l) |
1.2 ± 0.1 |
1.3 ± 0.1 |
0.170 |
| Triglycerides (mmol/l) | 1.7 ± 0.1 | 1.7 ± 0.1 | 0.928 |
Data are presented as mean ± SEM. 1)Analyzed by independent t-tests and the p-value represents the comparison to the placebo group. 2)Analyzed by Chi-square tests. BMI: body mass index.